
Microsoft-backed Graphcore has objected to Nvidia’s US$40 billion acquisition of Arm Holdings, according to a key member of the British chipmaker’s early development.
Hermann Hauser, who helped to create Arm in 1990, told CNBC that Graphcore has opposed the deal in a “major submission” to the UK’s Competition and Markets Authority.
“If Nvidia can merge the Arm and Nvidia designs in the same software then that locks out companies like Graphcore from entering the seller market and entering a close relationship with Arm,” said Hauser, who is an investor in Graphcore through his venture capital firm Amadeus Capital.
A spokesperson for Nvidia, which is planning to buy Arm from Japanese tech giant SoftBank, described the deal as “pro-competitive” on Wednesday, February 3. Arm did not immediately respond to a CNBC request for comment.
Graphcore isn’t the only tech firm that has objected to the transaction. Local chipmakers in China including Huawei have urged Beijing to try to block the deal over fears that they could be at a disadvantage if Arm ends up in the hands of a US company.
The deal is now being investigated by regulators around the world. The EU and the UK are set to open “in-depth competition investigations” into the deal.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas